Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01486407 · ClinicalTrials.gov registry record
Observational Study of Rapid Sequence Intubation Drug Delivery Using Intraosseous and Intravenous Access.
A clinical trial, sponsored by Vidacare Corporation.
- Terminated
- Registry status
- 4
- Enrollment target
NCT01486407 is a clinical trial that was terminated before completion, run by Vidacare Corporation. The registered enrollment target is 4 participants.
The verdict
NCT01486407 was terminated before completion, sponsored by Vidacare Corporation.
- TERMINATED
- Registry status
- 4 participants
- Enrollment target
Study Summary
This study will evaluate using intraosseous vascular access and intravenous vascular access to give patients the necessary medications to perform rapid sequence intubation, for patients with airway difficulties. The investigators think the device operator will find the intraosseous and intravenous routes equal for drug delivery.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4 participants |
| Start Date | 2012-02 |
| Est. Completion | 2012-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01486407
The ClinicalTrials.gov registry entry for NCT01486407 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 4 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Vidacare Corporation, which has 11 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT01486407 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01486407 about?
NCT01486407 is a clinical study titled "Observational Study of Rapid Sequence Intubation Drug Delivery Using Intraosseous and Intravenous Access.". This study will evaluate using intraosseous vascular access and intravenous vascular access to give patients the necessary medications to perform rapid sequence intubation, for patients with airway difficulties. The investigators think the device operator will find the intraosseous and intravenous r...
What is the current status of trial NCT01486407?
This trial is currently terminated. The enrollment target is 4 participants. The study started on 2012-02. Estimated completion is 2012-12.
Who is sponsoring clinical trial NCT01486407?
This trial is sponsored by Vidacare Corporation, which has 11 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.